Radient Enters Into Research Collaboration Agreement With CeTeCancer
Published: 15-Oct-2009
To identify early-detection and prevention program for lung cancer
Radient Pharmaceuticals (Radient) has entered into a collaboration agreement through its wholly owned subsidiary AMDL Diagnostics (ADI) with CeTeCancer to validate the effectiveness of its Onko-Sure in vitro diagnostic (IVD) cancer test as an early detection and prevention test for lung cancer.
Reportedly, ADI and CeTeCancer will collaborate on a research project entitled "Early Detection and Prevention of Lung Cancer Using Recent Advances in Genomics and Imagen" using the Onko-Sure cancer test kit.
The purpose of the research project is to identify an effective early-detection and prevention program for lung cancer. CeTeCancer will provide clinical samples and perform all clinical testing. The research project is supported by Innova Corfo and will run for 18 months with final results anticipated to be published in early 2011.
Douglas MacLellan, chairman and CEO of Radient, said: "We are delighted to enter into this partnership with a highly innovative scientific group working to detect and potentially prevent the deadly and worldwide spread of lung cancer. The expected results of this project should significantly accelerate the international commercialiSation of Onko-Sure."
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
Turku Region
A Bright Future in a Great Location ...
Toxikon Europe
CRO Providing Preclinical Safety Studies for the Life Science Community ...
TNO
Pharma Services: From Discovery to the Clinic ...
Thomson Reuters
The World's Leading Source of Life Sciences Intelligent Information ...
Taconic
Smart Solutions to Improve Human Health ...
White Papers
Browse A-Z
Your IP at Risk in Collaborations!
Free white paper: Ten steps to protect your R&D investment within partnerships. ...
Why, When and How to Conduct 14C Human Studies
Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...
Why CAPA Still Matters
This free white paper explores the needs and effectiveness of correct CAPA control, how to ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly
Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
